InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: Nomow post# 26356

Wednesday, 11/26/2014 5:33:11 AM

Wednesday, November 26, 2014 5:33:11 AM

Post# of 48316
$ONCS arrangement with Merck will be decisive as to whether $ONCS can partner with other Pharmas regarding Combo partnering in a P2B trial.

$ONCS has already partnered a deal with Plexxikon for mouse trials using Plexxikon's inhibitor CSF-1R

OncoSec Medical and Plexxikon Collaborate to Explore Combination Immunotherapy in Preclinical Tumor Studies.

Plexxikon is part of the Daiichi Sankyo Group

http://www.plexxikon.com/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News